|
Sunday, May 20
Welcome!
5:00 – 6:00 p.m.
Arrival & Registration;
Welcome Dinner
Duncan Hall
|
Monday, May 21
High-Resolution Optical Imaging
Duncan Hall, McMurtry Auditorium
Session Summary: Advances in high-resolution imaging techniques such as confocal, multiphoton and single-molecule microscopy provide tools for the study of dynamic physiological processes at the molecular, cellular, and tissue levels. Novel optical imaging systems enable better understanding of dynamic processes including protein interaction, cellular communication, and blood flow. Optical diagnostic imaging and intra operative imaging techniques provide capabilities for noninvasive early detection and improved treatment of cancer and other diseases.
8:00 – 9:00 a.m.
Registration & Continental Breakfast
Duncan Hall
9:00 – 10:00 a.m.
Keynote Address (45 min. talk, 15 min. discussion)
Advances in fiber-optic confocal reflectance microscopy
Mike Descour, Ph.D.
College of Optical Sciences
University of Arizona
Technical Presentations
10:00 - 10:30 a.m.
Ligand-directed tumor targeting and molecular imaging
Renata Pasqualini, Ph.D./
Wadih Arap, Ph.D.
Medicine and Cancer Biology
UT M. D. Anderson Cancer Center
10:30 - 11:00 a.m. Morning Break, Duncan Exhibit Hall
11:00 - 11:30 a.m.
Fast confocal imaging of blood flow and heart motions
Mary Dickinson, Ph.D.
Department of Molecular Physiology & Biophysics
Baylor College of Medicine
11:30 a.m. - 1:00 p.m. Lunch at Cohen House
1:00 - 1:30 p.m.
Single-molecule detection of biomotor-protein assemblies
Mike Diehl, Ph.D.
Department of Bioengineering
Rice University
1:30 - 2:00 p.m.
Confocal microscopy for imaging skin and oral cancers:
technology development & clinical applications
Milind Rajadhyaksha, Ph.D.
Dermatology Service
Memorial Sloan-Kettering Cancer Center
2:00 - 2:30 p.m.
Optical microscopy for in vivo high-resolution molecular
imaging of tumors
Rebecca Richards-Kortum, Ph.D.
Department of Bioengineering
Rice University
2:30 - 3:00 p.m. Afternoon Break, Duncan Exhibit Hall
3:00 - 3:30 p.m.
Rapid detection of physiological events in neurons using
two-photon microscopy
Peter Saggau, Ph.D.
Department of Neuroscience
Baylor College of Medicine
3:30 - 4:00 p.m.
Multispectral, non-linear and lifetime optical imaging
Peter So, Ph.D.
Mechanical and Biological Engineering
Massachusetts Institute of Technology
3:30 - 4:00 p.m.
Industrial Panel Discussion
Future trends in diagnostic imaging instrumentation
Marco Arrigoni
Director of Marketing
Scientific Segment
Coherent |
Angela Goodacre, M.S.
Applications Systems Manager
Life Sciences Group
Olympus America Inc. |
James R. Mansfield
Product Manager,
MSI Systems
Cambridge Research Inc (CRi) |
James A. Sharp
President
Carl Zeiss MicroImaging, Inc. |
5:00 – 7:00 p.m.
Poster Session and Reception
Grand Hall RMC (Located in the Rice Student Center)
|
Tuesday, May 22
Deep-Tissue Optical Imaging
Duncan Hall, McMurtry Auditorium
Session Summary: Deep-tissue optical imaging techniques allow functional imaging of intact tissues and organs, as well as whole-body studies of animal models. Optical tomographic techniques and multi-modal imaging techniques, particularly in combination with optical markers and probes, provide methods to characterize physiological function, investigate the development of disease, and analyze the effect of therapeutic interventions.
8:00 – 9:00 a.m.
Registration & Continental Breakfast
Duncan Hall
9:00 – 10:00 a.m.
Keynote Address (45 min. talk, 15 min. discussion)
Bioluminescent markers for studying cell biology in living animals
Christopher H. Contag, Ph.D.
Pediatrics - Neonatology
Stanford University
Technical Presentations
10:00 - 10:30 a.m.
Optical imaging of cerebral pathophysiology
Andrew K. Dunn, Ph.D.
Department of Biomedical Engineering
University of Texas at Austin
10:30 - 11:00 a.m. Morning Break, Duncan Exhibit Hall
11:00 - 11:30 a.m.
Noninvasive determination of the optical properties in tissues:
near-infrared spectroscopy approach
Enrico Gratton, Ph.D.
Biomedical Engineering and Physics
University of California - Irvine
11:30 a.m. - 1:00 p.m. Lunch at Cohen House
1:00 - 1:30 p.m.
Volumetric tomography of fluorescent reporters through small
animals in vivo
Vasilis Ntziachristos, Ph.D.
Department of Radiology
Harvard University & Massachusetts General Hospital
1:30 - 2:00 p.m.
Deep-tissue imaging for cancer diagnosis
Eva Sevick-Muraca, Ph.D.
Department of Radiology
Baylor College of Medicine
2:00 - 2:30 p.m.
High-resolution photoacoustic tomography
Lihong Wang, Ph.D.
Department of Biomedical Engineering
Washington University, St. Louis
2:30 - 3:00 p.m. Afternoon Break, Duncan Exhibit Hall
3:00 - 3:30 p.m.
Novel tracers for early cancer detection, profiling and treatment
Juri G. Gelovani, M.D., Ph.D.
Department of Experimental Diagnostic Imaging
The University of Texas M.D. Anderson Cancer Center
3:30 - 4:00 p.m.
Molecular image-guided therapy: a systems approach
Steven Wong, Ph.D.
Departments of Radiology and Medical Physics
Methodist Hospital - Weill Medical College of Cornell University
4:00 - 5:00 p.m.
Industrial Panel Discussion
Future trends in multi-modal imaging and image-guided intervetion
Stephen J. Lomnes
Manager,
Biomedical Optics Research
Technology & Medical Organization
GE Healthcare |
Paul McLaughlin, Ph.D.
Program Leader,
Optical Diagnostics
Health Group Research & Innovation
Carestream Health, Inc. |
Eduardo Ruvolo
Research Fellow
Johnson & Johnson |
Christian Schultz, Ph.D.
Director,
Molecular Imaging,
Global Business Development
Siemens Medical Solutions USA, Inc |
5:00 – 6:00 p.m.
Networking Reception
Duncan Hall
|
Wednesday, May 23
Contrast Agents and Molecular Beacons
Duncan Hall, McMurtry Auditorium
Session Summary: Molecular-specific contrast agents provide improved capabilities for detection, diagnosis, and treatment of disease. Improved understanding of biological processes at the molecular level, and the identification of molecular biomarkers for cancer and other diseases, have led to the development of contrast agents for optimized diagnostic imaging, characterization of intracellular functions, and targeted therapy. The combination of diagnostic imaging with molecular characterization of disease provides new methods for early detection, risk assessment, selection of molecular therapy, and response monitoring.
8:00 – 9:00 a.m.
Registration & Continental Breakfast
Duncan Hall
9:00 – 10:00 a.m.
Keynote Address (45 min. talk, 15 min. discussion)
Coordination chemistry and molecular imaging:
eliminating the background
Thomas J. Meade, Ph.D.
Department of Chemistry
Northwestern University
Technical Presentations
10:00 - 10:30 a.m.
Nanostructured probes and molecular beacons for
in vivo
detection of cells
Gang Bao, Ph.D.
Department of Biomedical Engineering
Georgia Institute of Technology
10:30 - 11:00 a.m. Morning Break, Duncan Exhibit Hall
11:00 - 11:30 a.m.
Molecule-specific optical contrast agents
Rebekah Drezek, Ph.D.
Department of Bioengineering
Rice University
11:30 a.m. - 1:00 p.m. Box Lunches at Duncan Hall
1:00 - 1:30 p.m.
Multi-modal contrast agents for image-guided interventions
Chun Li, Ph.D.
Department of Experimental Diagnostic Imaging
UT M. D. Anderson Cancer Center
1:30 - 2:00 p.m.
Contrast agents for imaging cellular physiology
and
cell-to-cell communication
Wen Hong Li, Ph.D.
Cell Biology and Biochemistry
UT Southwestern Medical Center
2:00 - 2:30 p.m.
Optically active contrast agents to monitor receptor
expression and interactions
Konstantin Sokolov, Ph.D.
Center for Biomedical Engineering
UT M. D. Anderson Cancer Center
2:30 - 3:00 p.m. Afternoon Break, Duncan Exhibit Hall
3:00 - 3:30 p.m.
Enzyme activity and disease imagaing
Ching Tung, Ph.D.
Center for Molecular Imaging Research
Massachusetts General Hospital
Harvard Medical School
3:30 - 4:00 p.m.
Industrial Panel Discussion
Future trends in contrast agents and beacons
Larry Greenfield, M.D., Ph.D
Director, Research & Development
Invitrogen |
Alexandra de Lille, Ph.D., DVM
Caliper Life Sciences |
Gang Bao, Ph.D.
Professor
Georgia Institute of Technology
|
|
|
|
|